Pharmaceuticals
Pfizer in advanced talks to buy cancer drug specialist Medivation for nearly $14 bn
22 Aug 2016
A successful deal would be Pfizer’s biggest acquisition since it purchased biologic drug specialist Hospira Inc last year for about $17 billion